Takeshi Nakanishi
Overview
Explore the profile of Takeshi Nakanishi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
193
Citations
1249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito T, Kukino R, Sarayama Y, Tanioka M, Maekawa T, Yatsushiro H, et al.
J Dermatol
. 2024 Dec;
52(2):e49-e69.
PMID: 39723550
"Wound, Pressure Ulcer, and Burn Guidelines-5: Guidelines for the management of lower leg ulcers and varicose veins, second edition" is revised from the first edition, which was published in the...
2.
Yoshida J, Kato Y, Isogawa A, Tanaka Y, Kumagai I, Asano R, et al.
J Biol Eng
. 2024 Oct;
18(1):57.
PMID: 39402666
During the production of bispecific antibodies (bsAbs), nonspecific pairing results in low yields of target bsAb molecules, an issue known as the "mispairing problem." Several antibody engineering techniques have been...
3.
Nakanishi T, Kuragano T
Clin Kidney J
. 2024 Mar;
17(3):sfae051.
PMID: 38516524
Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) have emerged as a novel therapeutic class for treating anemia in patients with chronic kidney disease. Small molecule analogs of α-ketoglutarate (AKG), an essential...
4.
Nakanishi M, Goto A, Iwasaki T, Nakanishi T, Kuma A, Nanami M, et al.
BMC Nephrol
. 2023 Dec;
24(1):373.
PMID: 38102596
Background: Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with chronic kidney disease (CKD) and could be related to oxidative stress. Vascular calcification (VC) has...
5.
Nagasawa M, Inoue R, Nakanishi T, Morita K
Rev Sci Instrum
. 2023 Dec;
94(8).
PMID: 38065155
An improved method to simultaneously determine the heat capacity, thermal diffusivity, and thermal conductivity of a small-sized material is described. In this method, the heat of a square wave with...
6.
Cancer therapeutic trispecific antibodies recruiting both T and natural killer cells to cancer cells
Kimura K, Kuwahara A, Suzuki S, Nakanishi T, Kumagai I, Asano R
Oncol Rep
. 2023 Oct;
50(6).
PMID: 37859608
T cells and natural killer (NK) cells are major effector cells recruited by cancer therapeutic bispecific antibodies; however, differences in the populations of these cells in individual tumors limit the...
7.
Yamada R, Nakahara I, Kumagai I, Asano R, Nakanishi T, Makabe K
Sci Rep
. 2023 Sep;
13(1):15961.
PMID: 37749185
A bispecific antibody (bsAb) is a class of engineered antibody molecules that simultaneously binds to two different antigens by having two kinds of antigen-binding domains. One of the major obstacles...
8.
Kokubu H, Takahashi T, Shiohara M, Matsubara A, Kato T, Nakanishi T, et al.
Eur J Dermatol
. 2023 Aug;
33(3):314-316.
PMID: 37594349
No abstract available.
9.
Sugiura S, Nakanishi T, Fujimoto N
Eur J Dermatol
. 2023 Aug;
33(3):307-309.
PMID: 37594345
No abstract available.
10.
Kokubu H, Nakanishi T, Kato T, Fujimoto N
Case Rep Oncol
. 2023 Jun;
16(1):347-350.
PMID: 37384211
We present a rare phenomenon of a soft tumor hanging on the woman's left upper arm that underwent necrosis from the distal aspect during chemotherapy for pancreatic cancer. The benign...